BSE filing, BSE: 544417. Summary written from the filing by ALFA Finder's alert engine.
Aten Papers & Foam Ltd: key numbers
- Share price
- ₹22.00
- Market cap
- ₹22.66 Cr
- Revenue (annual)
- ₹186.7 Cr
- Net profit (annual)
- ₹7.39 Cr
- P/E (TTM)
- 3.1×Sector 36.4×
- Promoter holding
- 67.96%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aten Papers & Foam Ltd
All →Aten Papers & Foam Annual General Meeting
Aten Papers & Foam Ltd held its 8th Annual General Meeting on September 30, 2026. The meeting discussed and considered various business items listed in the notice.
Aten Papers & Foam Management Change
Aten Papers & Foam Limited announced the appointment of Raghav Jobanputra as Independent Director, the resignation of Premaram Patel, and re-appointment of MD Mohamedarif Lakhani.
Aten Papers & Foam Annual General Meeting
Aten Papers & Foam Limited issued a notice for its Annual General Meeting on September 30, 2026, to transact various business items including director appointments and RPT approvals.
Aten Papers & Foam Annual Report
Aten Papers & Foam Limited has submitted its Annual Report for the financial year 2025-26, incorporating the notice for the 8th Annual General Meeting.
Aten Papers & Foam Board Meeting Outcome
The board appointed new auditors and a director, reconstituted committees, re-appointed the Managing Director, and approved the 8th AGM notice. Related party transactions were also noted.
Aten Papers & Foam Management Change
Aten Papers & Foam Limited appointed Mr. Mahendrakumar Kumavat as Company Secretary and Compliance Officer. The appointment is effective from July 10, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.